Devatis Limited

Devatis Limited is a licensed pharmaceutical company in New Zealand. Being active since 2007 in New Zealand, the company was initially incorporated as DEVA Holdings NZ Ltd and amended its name as Devatis Limited as of March 20, 2017. Devatis Limited is 100% owned by DEVA Holding A.S. which is one of the leading pharmaceutical companies in Turkey. Through DEVA Holding A.S., Devatis Ltd. is a part of globally active EastPharma group companies. Having an enterprising and innovative attitude in the pharmaceutical market, DEVA Holding A.S. is active in several important territories all over the world. The essential aim is to make perfect quality medicines available for everyone. In this respect, DEVA is working devotedly at its EU-GMP and US FDA approved, state-of-art manufacturing facilities with approximately 2500 employees.


Established in 1958, DEVA Holding has approximately 600 products in in the Turkish pharmaceuticals market and with excellent manufacturing capabilities for nearly all kind of pharmaceutical forms, DEVA develops, produces, markets and sells its high-quality finished products, APIs and veterinary products worldwide. DEVA offers a wide range of products in various therapeutical areas including antibacterial, antineoplastic, musculoskeletal, cardiovascular, gastrointestinal, respiratory, central nervous system, dermatology and hormones.


Comprehensive Product Portfolio

DEVA Holding has more than 650 products in 14 therapeutic areas including Hematology & oncology, ophthalmology and respiratory system products amongst others creating difference by launching new products into market every single year.

Manufacturing Capabilities

DEVA production facilities have been approved and certified by EU GMP and US FDA with an annual output capacity of 578 million units. Manufacturing capacity allows production of different pharmaceutical forms at large scales:


  • Tablets
  • Coated Tablets
  • Enteric – Coated Tablets
  • Bilayer Tablets
  • Chewable tablets
  • Capsules
  • Micropellet Capsules
  • Softgel Capsules
  • Sugar Coated Pills
  • Syrups
  • Suspensions
  • Creams
  • Pomades
  • Ointments
  • Drops
  • Sprays
  • Gels
  • Suppositories
  • MDI (Metered Dose Inhaler)
  • DPI (Dry Powder Inhaler)


  • Ampoules
  • Vial
  • Lyophilized Vial
  • Eye drop & Nebul
  • Sterile Animal Health

Established Quality Standards

The high quality of DEVA production facilities are endorsed by globally recognized certification bodies:

  •  EU – GMP (German Health Authority - Baden Württemberg, Portuguese Health Authority - Infarmed)
  •  FDA (U.S. Food and Drug Administration)
  •  MedSafe (New Zealand Medicines and Medical Devices Safety Authority)
  •  ISO 9001 Quality Management System
  •  ISO 27001 Information Security Management System
  •  ISO 14001 Environmental Management System
  •  BS OHSAS 18001 Occupational Health and Safety Management

Manufacturing Facilities

DEVA has three manufacturing facilities which are endorsed by internationally recognized certifications proving the high quality standards of DEVA.

Location: Çerkezkoy/Turkey

 Solid Manufacturing Unit

  • Dry powder suspensions
  • Tablets
  • Chewable tablets
  • Bilayer tablets
  • Capsules

 Liquid / Semi Solid Manufacturing Unit

  • Creams, pomades & gels
  • Eye pomads
  • Suppozituar
  • Drops
  • Syrup

 Cephalosporin Manufacturing Unit

  • Sterile powder vial
  • Dry suspensions
  • Tablets
  • Capsules

 Penicilin Manufacturing Unit

  • Sterile powder vial
  • Dry suspensions
  • Tablets

 Hormone Products Manufacturing Unit (Non sterile)

  • Tablets
  • Coated Tablets
  • Creams - Gels - Pomades
  • Lotion & packaging

 Hormone Products Manufacturing Unit (Sterile)

  • Ampoules
  • Vial
  • Drops

 Inhaled Products

  • MDI (Metered Dose Inhaler)
  • DPI (Dry powder Inhaler)  

 Sterile Liquid Vial and Soft Gel Capsule Products

  • Sterile Liquid Vial
  • Sterile Liquid Ampoules
  • Soft Gel Capsule

Location: Turkey’s Largest Logistics Center

Turkey's largest pharmaceutical logistics center with 58,000 m2 total land area, which received EU GMP approval, conducts its activities with a capacity of 43,500 pallets.

API Production Units

  • Non-betalactam
  • Oncolytic

Human Finished Dosage Forms Production Units

  • Solid Oncolytics (tablets & capsules)
  • Sterile Liquid Oncolytics (liquid & lyophilized vials)

Animal Health Products Production Units

Solids (tablets & powders)

Location: Kartepe/Turkey

Empty& filled ampoule production

  • 1ml - 20ml

 Sterile vial & lyophilisation production

  • 0,5ml - 200ml

 SVP production with BFS technology

  • Unit dose: 0.35 ml – 3 ml (LDPE)
  • Multidose & Inj: 2.5ml - 10 ml (LDPE)

 Eye drop production in sterile PE bottle

  • 2ml – 10 ml

 Cologne production